Table 1.
Enteroviral Isolates | No. (%) | Subjects (%) | Locations (%) | ||
Study Groups |
Control Groups |
FMC, | UCH, | ||
Coxsackie-B5-virus | 10 (27.8) | + | − | + | + |
Echovirus 7 | 2 (5.6) | + | − | − | + |
Echovirus 11 | 4 (11.1) | + | − | + | + |
Echovirus 9 | 2 (5.6) | + | − | − | + |
Echovirus 6 | 4 (11.1) | + | − | + | + |
Coxsackievirus-A9 | 2 (5.6) | + | − | + | + |
Echovirus 1 | 1 (2.8) | + | − | + | − |
Echovirus 22 | 1 (2.8) | + | − | + | − |
Echovirus 12 | 2 (5.6) | + | − | + | + |
Echovirus 30 | 2 (5.6) | + | − | − | + |
Poliovirus 1 (PV1) | 2 (5.6) | + | − | + | + |
Poliovirus 3 (PV3) | 2 (5.6) | + | − | + | + |
PV1+PV3 Mixtures | 2 (5.6) | + | + | + | + |
Total | 36 (100.0) | 35(97.2) | 1(2.8) | 7(19.4) | 29(80.6) |